Amylin, Lilly and Alkermes resubmit Bydureon with FDA

 
• By Asher Mullard
  
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Anticancer

More from Therapeutic Category